Antihyperalgesic/Antinociceptive effects of ceftriaxone and its synergistic interactions with different analgesics in inflammatory pain in rodents

Anesthesiology

Volumn 120, Issue 3, 2014, Pages 737-750

  Stepanovic Petrovic', Radica M ^a   Micov, Ana M ^a   Tomic', Maja A ^a   Kovacevic', Jovana M ^a   Boškovic', Bogdan D ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; CEFTRIAXONE; CELECOXIB; ETIRACETAM; IBUPROFEN; LONGACEPH; PARACETAMOL; UNCLASSIFIED DRUG;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFICACY; DRUG POTENTIATION; HYPERALGESIA; INFLAMMATORY PAIN; MALE; MOUSE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; RAT; ROTAROD TEST; SOMATIC PAIN; TREATMENT DURATION; VISCERAL PAIN; WRITHING TEST;

ACETAMINOPHEN; ANALGESICS; ANALGESICS, NON-NARCOTIC; ANIMALS; ANTI-BACTERIAL AGENTS; CEFTRIAXONE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; HYPERALGESIA; IBUPROFEN; INFLAMMATION; MALE; PAIN; PIRACETAM; PYRAZOLES; RATS; RATS, WISTAR; SULFONAMIDES;

EID: 84895437430     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0000435833.33515.ba     Document Type: Article

References (57)

1. Millan MJ: The induction of pain: An integrative review. Prog Neurobiol 1999; 57:1-164
2. Salter MW: Cellular signalling pathways of spinal pain neuroplasticity as targets for analgesic development. Curr Top Med Chem 2005; 5:557-67
3. Woolf CJ, Salter MW: Neuronal plasticity: Increasing the gain in pain. Science 2000; 288:1765-9
4. Carlton SM, Hargett GL, Coggeshall RE: Localization and activation of glutamate receptors in unmyelinated axons of rat glabrous skin. Neurosci Lett 1995; 197:25-8
5. Wang H, Liu RJ, Zhang RX, Qiao JT: Peripheral NMDA receptors contribute to activation of nociceptors: A c-fos expression study in rats. Neurosci Lett 1997; 221:101-4
6. Beart PM, OShea RD: Transporters for l-glutamate: An update on their molecular pharmacology and pathological involvement. Br J Pharmacol 2007; 150:5-17
7. Robinson MB: The family of sodium-dependent glutamate transporters: A focus on the GLT-1/EAAT2 subtype. Neurochem Int 1998; 33:479-91
8. Rothstein JD, Dykes-Hoberg M, Pardo CA, Bristol LA, Jin L, Kuncl RW, Kanai Y, Hediger MA, Wang Y, Schielke JP, Welty DF: Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 1996; 16:675-86
9. Carozzi VA, Canta A, Oggioni N, Ceresa C, Marmiroli P, Konvalinka J, Zoia C, Bossi M, Ferrarese C, Tredici G, Cavaletti G: Expression and distribution of high affinity glutamate transporters GLT1, GLAST, EAAC1 and of GCPII in the rat peripheral nervous system. J Anat 2008; 213:539-46
10. Rothstein JD, Patel S, Regan MR, Haenggeli C, Huang YH, Bergles DE, Jin L, Dykes Hoberg M, Vidensky S, Chung DS, Toan SV, Bruijn LI, Su ZZ, Gupta P, Fisher PB: Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression. Nature 2005; 433:73-7
11. Hu Y, Li W, Lu L, Cai J, Xian X, Zhang M, Li Q, Li L: An antinociceptive role for ceftriaxone in chronic neuropathic pain in rats. Pain 2010; 148:284-301
12. Gunduz O, Oltulu C, Buldum D, Guven R, Ulugol A: Antiallodynic and anti-hyperalgesic effects of ceftriaxone in streptozocin- induced diabetic rats. Neurosci Lett 2011; 491:23-5
13. Lin Y, Roman K, Foust KD, Kaspar BK, Bailey MT, Stephens RL: Glutamate transporter GLT-1 upregulation attenuates visceral nociception and hyperalgesia via spinal mechanisms not related to anti-inflammatory or probiotic effects. Pain Res Treat 2011; 2011:507029
14. Dray A: Inflammatory mediators of pain. Br J Anaesth 1995; 75:125-31
15. Robinson DR, Gebhart GF: Inside information: The unique features of visceral sensation. Mol Interv 2008; 8:242-53
16. Ferreira SH, Prado WA, Ferrari LF: Potassium and calcium channels in pain pharmacology, Pharmacology of Pain. Edited by Beaulieu P, Lusser D, Porreca F, Dickenson A. Seattle, IASP Press, 2010, pp 163-84
17. Amin B, Hajhashemi V, Hosseinzadeh H, Abnous Kh: Antinociceptive evaluation of ceftriaxone and minocycline alone and in combination in a neuropathic pain model in rat. Neuroscience 2012; 224:15-25
18. Horvath G, Kekesi G: Interaction of endogenous ligands mediating antinociception. Brain Res Rev 2006; 52:69-92
19. Hinz B, Cheremina O, Brune K: Acetaminophen (paracetamol) is a selective cyclooxygenase-2 inhibitor in man. FASEB J 2008; 22:383-90
20. Hinz B, Brune K: Paracetamol and cyclooxygenase inhibition: Is there a cause for concern? Ann Rheum Dis 2012; 71:20-5
21. Micov A, Tomić M, Popović B, Stepanović- Petrović R: The antihyperalgesic effect of levetiracetam in an inflammatory model of pain in rats: Mechanism of action. Br J Pharmacol 2010; 161:384-92
22. Stepanović-Petrović RM, Micov AM, Tomić MA, Ugrešić ND: The local peripheral antihyperalgesic effect of levetiracetam and its mechanism of action in an inflammatory pain model. Anesth Analg 2012; 115:1457-66
23. De Smedt T, Raedt R, Vonck K, Boon P: Levetiracetam: The profile of a novel anticonvulsant drug-part I: Preclinical data. CNS Drug Rev 2007; 13:43-56
24. National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals: Guide for the Care and Use of Laboratory Animals, 8th edition. Washington, National Academies Press (US), 2011
25. Tomić MA, Vučković SM, Stepanović- Petrović RM, Ugrešić N, Prostran MŠ, Bošković B: The anti-hyperalgesic effects of carbamazepine and oxcarbazepine are attenuated by treatment with adenosine receptor antagonists. Pain 2004; 111:253-60
26. Tomić MA, Vučković SM, Stepanović- Petrović RM, Ugrešić ND, Prostran MŠ, Bošković B: Synergistic interactions between paracetamol and oxcarbazepine in somatic and visceral pain models in rodents. Anesth Analg 2010; 110:1198-205
27. Stepanović-Petrović RM, Tomić MA, Vučković SM, Poznanović G, Ugrešić ND, Prostran MŠ, Bošković B: Pharmacological interaction between oxcarbazepine and two COX inhibitors in a rat model of inflammatory hyperalgesia. Pharmacol Biochem Behav 2011; 97:611-8
28. Morris CJ: Carrageenan-induced paw edema in the rat and mouse, Inflammation Protocols (Methods in Molecular Biology). Edited by Winyard PG, Willoughby DA, Vol 225 Totowa, Humana Press Inc., 2003, pp 115-23
29. Francischi JN, Chaves CT, Moura AC, Lima AS, Rocha OA, Ferreira-Alves DL, Bakhle YS: Selective inhibitors of cyclooxygenase- 2 (COX-2) induce hypoalgesia in a rat paw model of inflammation. Br J Pharmacol 2002; 137:837-44
30. Stepanović-Petrović RM, Tomić MA, Vučković SM, Paranos S, Ugrešić ND, Prostran MŠ, Milovanović S, Bošković B: The antinociceptive effects of anticonvulsants in a mouse visceral pain model. Anesth Analg 2008; 106:1897-903
31. Tallarida RJ, Stone DJ Jr, Raffa RB: Efficient designs for studying synergistic drug combinations. Life Sci 1997; 61:PL 417-25
32. Tallarida RJ: The interaction index: A measure of drug synergism. Pain 2002; 98:163-8
33. Tallarida RJ, Murray RB: Manual of Pharmacologic Calculations with Computer Programs, 2nd edition. New York, Berlin, Heidelberg, London, Paris, Tokyo, Springer Verlag, 1986
34. Yaksh TL, Noueihed RY, Durant PA: Studies of the pharmacology and pathology of intrathecally administered 4-anilinopiperidine analogues and morphine in the rat and cat. Anesthesiology 1986; 64:54-66
35. Kimura M, Hayashida K, Eisenach JC, Saito S, Obata H: Relief of hypersensitivity after nerve injury from systemic donepezil involves spinal cholinergic and ?-aminobutyric acid mechanisms. Anesthesiology 2013; 118:173-80
36. Rylander D, Recchia A, Mela F, Dekundy A, Danysz W, Cenci MA: Pharmacological modulation of glutamate transmission in a rat model of l-DOPA-induced dyskinesia: Effects on motor behavior and striatal nuclear signaling. J Pharmacol Exp Ther 2009; 330:227-35
37. Lin Y, Tian G, Roman K, Handy C, Travers JB, Lin CL, Stephens RL Jr: Increased glial glutamate transporter EAAT2 expression reduces visceral nociceptive response in mice. Am J Physiol Gastrointest Liver Physiol 2009; 296: G129-34
38. Yang M, Roman K, Chen DF, Wang ZG, Lin Y, Stephens RL Jr: GLT-1 overexpression attenuates bladder nociception and local/cross-organ sensitization of bladder nociception. Am J Physiol Renal Physiol 2011; 300:F1353-9
39. Suyama H, Kawamoto M, Gaus S, Yuge O: Effect of etodolac, a COX-2 inhibitor, on neuropathic pain in a rat model. Brain Res 2004; 1010:144-50
40. Basbaum AI, Bautista DM, Scherrer G, Julius D: Cellular and molecular mechanisms of pain. Cell 2009; 139:267-84
41. Carlton SM: Peripheral excitatory amino acids. Curr Opin Pharmacol 2001; 1:52-6
42. Okano K, Kuraishi Y, Satoh M: Involvement of spinal substance P and excitatory amino acids in inflammatory hyperalgesia in rats. Jpn J Pharmacol 1998; 76:15-22
43. Chen W, Mahadomrongkul V, Berger UV, Bassan M, DeSilva T, Tanaka K, Irwin N, Aoki C, Rosenberg PA: The glutamate transporter GLT1a is expressed in excitatory axon terminals of mature hippocampal neurons. J Neurosci 2004; 24:1136-48
44. Giamberardino MA: Recent and forgotten aspects of visceral pain. Eur J Pain 1999; 3:77-92
45. Ribeiro RA, Vale ML, Thomazzi SM, Paschoalato AB, Poole S, Ferreira SH, Cunha FQ: Involvement of resident macrophages and mast cells in the writhing nociceptive response induced by zymosan and acetic acid in mice. Eur J Pharmacol 2000; 387:111-8
46. Watkins LR, Maier SF: Beyond neurons: Evidence that immune and glial cells contribute to pathological pain states. Physiol Rev 2002; 82:981-1011
47. Tong C, Conklin D, Eisenach JC: A pain model after gynecologic surgery: The effect of intrathecal and systemic morphine. Anesth Analg 2006; 103:1288-93
48. Kfoury T, Mazoit JX, Schumacher M, Benhamou D, Beloeil H: A comparison of different dosages of a continuous preperitoneal infusion and systemic administration of ropivacaine after laparotomy in rats. Anesth Analg 2011; 113:617-25
49. Yoon MH, Yaksh TL: Evaluation of interaction between gabapentin and ibuprofen on the formalin test in rats. Anesthesiology 1999; 91:1006-13
50. Baba H, Kohno T, Moore KA, Woolf CJ: Direct activation of rat spinal dorsal horn neurons by prostaglandin E2. J Neurosci 2001; 21:1750-6
51. Yaksh TL, Dirig DM, Conway CM, Svensson C, Luo ZD, Isakson PC: The acute antihyperalgesic action of nonsteroidal, antiinflammatory drugs and release of spinal prostaglandin E2 is mediated by the inhibition of constitutive spinal cyclooxygenase- 2 (COX-2) but not COX-1. J Neurosci 2001; 21:5847-53
52. Feng Y, Cui M, Willis WD: Gabapentin markedly reduces acetic acid-induced visceral nociception. Anesthesiology 2003; 98:729-33
53. McCormack K: Non-steroidal anti-inflammatory drugs and spinal nociceptive processing. Pain 1994; 59:9-43
54. Dirig DM, Isakson PC, Yaksh TL: Effect of COX-1 and COX-2 inhibition on induction and maintenance of carrageenan-evoked thermal hyperalgesia in rats. J Pharmacol Exp Ther 1998; 285:1031-8
55. Yoshino T, Kimoto A, Kobayashi S, Noguchi M, Fukunaga M, Hayashi A, Miyata K, Sasamata M: Pharmacological profile of celecoxib, a specific cyclooxygenase-2 inhibitor. Arzneimittelforschung 2005; 55:394-402
56. Bonnefont J, Chapuy E, Clottes E, Alloui A, Eschalier A: Spinal 5-HT1A receptors differentially influence nociceptive processing according to the nature of the noxious stimulus in rats: Effect of WAY-100635 on the antinociceptive activities of paracetamol, venlafaxine and 5-HT. Pain 2005; 114:482-90
57. Rezende RM, França DS, Menezes GB, dos Reis WG, Bakhle YS, Francischi JN: Different mechanisms underlie the analgesic actions of paracetamol and dipyrone in a rat model of inflammatory pain. Br J Pharmacol 2008; 153:760-8